Frankenfield Christopher James's Form 4 filing
Xilio Therapeutics, Inc. (XLO) · filed Jan 5, 2026
- Accession no.
- 0001193125-26-002517
- Filed
- Jan 5, 2026
- Trade date
- Dec 31, 2025-Jan 2, 2026
- Filing delay
- 5 days
- Rule 10b5-1 plan
- Checked
This filing lists 2 non-derivative transactions and 2 derivative transactions. Open-market sales total $4.50K. It was filed 5 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Frankenfield Christopher JamesCIK 0001988344 | Officer (Chief Financial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 1, 2026 | Common Stock | MOption exerciseAcquired | +19,375 | –F1 | – | 31,796 | Direct | |
| Jan 2, 2026 | Common Stock | SSaleDisposed | −7,030 | $0.64 | −$4,499.2 | 24,766 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 31, 2025 | Common Stock | AGrant or awardAcquired | +668,789 | $0.00 | $0 | 668,789 | Direct | |
| Jan 1, 2026 | Common Stock | MOption exerciseDisposed | −19,375 | $0.00 | $0 | 38,750 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
Restricted stock units ("RSUs") convert to stock on a one-for-one basis.
Referenced by the price of 1 transaction in Table I.